Kitov Pharmaceuticals Holdings Ltd (NASDAQ:KTOV) fell 2.9% during trading on Tuesday . The company traded as low as $2.98 and last traded at $3.01, with a volume of 146,483 shares. The stock had previously closed at $3.10.

A number of brokerages have commented on KTOV. Rodman & Renshaw restated a “buy” rating on shares of Kitov Pharmaceuticals Holdings in a research report on Monday. Zacks Investment Research lowered Kitov Pharmaceuticals Holdings from a “buy” rating to a “hold” rating in a research report on Tuesday, June 28th.

The stock’s market capitalization is $12.06 million. The stock’s 50 day moving average is $4.05 and its 200 day moving average is $3.99.

Kitov Pharmaceuticals Holdings Ltd is an Israel-based company that develops non-steroidal anti-inflammatory drugs that treat pain without raising blood pressure, thus avoiding the increased risk of heart attacks, strokes or death.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.